Cover Image

Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis

Objective: We evaluated both the efficacy and safety of anakinra in daily routine rheumatoid arthritis clinical practice. Methods:We studied 60 cases, including patients with previous anti-TNFα exposure, treated with anakinra (100 mg/daily s.c.) in combination with methotrexate (7.5-10 mg/week i.m.)...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. Todesco (Author), U. Fiocco (Author), M. Biscaro (Author), P. Ostuni (Author), A. Furlan (Author), P. Sfriso (Author), C. Botsios (Author), L. Punzi (Author)
Format:	Book
Published:	PAGEPress Publications, 2011-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects
by: C. Botsios, et al.
Published: (2003)

IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy
by: L. Cozzi, et al.
Published: (2011)

Incidence and management of infusion reactions to infliximab in 186 italian patient's with rheumatoid arthritis: the Padua experience
by: S. Todesco, et al.
Published: (2011)

TNFα blockers and infectious risk in rheumatoid arthritis
by: S. Todesco, et al.
Published: (2011)

The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis
by: L. Riente
Published: (2011)

Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab
by: L. Punzi, et al.
Published: (2011)

Recurrent poliserositis succesfully treated with IL-1 receptor antagonist Anakinra
by: Santa-María V, et al.
Published: (2011)

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions
by: Mahamid M, et al.
Published: (2011)

Pilot Study of IL-1 Antagonist Anakinra for Treatment of Endometriosis
by: Sullender RT, et al.
Published: (2024)

On the history of biological drugs: the true discovery of the IL-1 receptor antagonist On the history of biological drugs: the true discovery of the IL-1 receptor antagonist
by: P. Marson, et al.
Published: (2012)

Nasopharyngeal carcinoma and Dermatomyositis: a case report
by: C. Botsios, et al.
Published: (2002)

High expression of interleukine-1 receptor antagonist in rheumatoid arthritis: Association with IL1RN*2/2 genotype
by: S. Ramírez-Pérez, et al.
Published: (2017)

Usefulness of interleukin 1 receptor antagonist (anakinra) in refractory post-pericardiotomy syndrome
by: Marta Flores Fernández, et al.
Published: (2021)

Differences in pharmacology of tumor necrosis factor (TNF) antagonists
by: S. Bombardieri, et al.
Published: (2011)

Post-traumatic arthritis in patient with Jadassohn's anetoderma
by: C. Circhetta, et al.
Published: (2003)

Imaging in major salivary gland diseases
by: C. Botsios, et al.
Published: (2001)

Kidney involvement in rheumatoid arthritis
by: A. Icardi, et al.
Published: (2003)

Editorial: IL-1 Inhibition
by: Francesca Oliviero, et al.
Published: (2019)

Anakinra treatment in patients with systemic-onset juvenil idiopathic arthritis: "The Valencia Experience"
by: Montesinos B, et al.
Published: (2011)

IL-1Ra: its role in rheumatoid arthritis
by: M. Cutolo
Published: (2011)

Switching between TNFα antagonists in rheumatoid arthritis: personal experience and review of the literature
by: M. Di Franco, et al.
Published: (2011)

Peri- and Postoperative Treatment with the Interleukin-1 Receptor Antagonist Anakinra Is Safe in Patients Undergoing Renal Transplantation: Case Series and Review of the Literature
by: Catharina M. Mulders-Manders, et al.
Published: (2017)

Anakinra in systemic juvenile idiopathic arthritis (soJIA) non responsive to antiTNF
by: Pontikaki I, et al.
Published: (2008)

Familial mediterranean fever and pauciimmune renal vasculitis: the role of IL-1 blockade (Anakinra)
by: Sánchez A, et al.
Published: (2011)

Reumatismo On-line, one year after
by: L. Punzi, et al.
Published: (2003)

Differences of IL-1β Receptors Expression by Immunocompetent Cells Subsets in Rheumatoid Arthritis
by: Alina A. Alshevskaya, et al.
Published: (2015)

Prevalence of erosive osteoarthritis of the hand in a population from venitian area
by: F. Cavasin, et al.
Published: (2004)

Early rheumatoid arthritis
by: P. Sarzi-Puttini, et al.
Published: (2011)

Intra-articular etanercept treatment for severe diffuse pigmented villonodular knee synovitis
by: C. Giacometti, et al.
Published: (2011)

Long-term follow-up of systemic onset juvenile idiopathic arthritis patients treated with Anakinra
by: Martini Alberto, et al.
Published: (2011)

Application of anakinra in inflammatory dermatoses
by: Xiaomei YOU, et al.
Published: (2024)

Continuous IV infusion of anakinra
by: Brittney N. Saunders, et al.
Published: (2023)

Enigma of IL-17 and Th17 Cells in Rheumatoid Arthritis and in Autoimmune Animal Models of Arthritis
by: Reka Kugyelka, et al.
Published: (2016)

Experience of one UK site presenting a closer examination of safety and efficacy of Anakinra (Kineret<sup>®</sup>) in systemic juvenile idiopathic arthritis
by: Livermore P, et al.
Published: (2008)

A Role of IL-17 in Rheumatoid Arthritis Patients Complicated With Atherosclerosis
by: Jiexin Wang, et al.
Published: (2022)

On the Role of sIL-2R Measurements in Rheumatoid Arthritis and Cancers
by: Anna Maria Witkowska
Published: (2005)

Safety of rituximab in rheumatoid arthritis
by: F. Atzeni, et al.
Published: (2011)

LABORATORY FINDINGS IN PSORIATIC ARTHRITIS
by: S. Todesco, et al.
Published: (2011)

Anakinra for systemic onset juvenile idiopathic arthritis: experience as a second versus first line treatment
by: Anton J, et al.
Published: (2011)

Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease
by: Jurgen Sota, et al.
Published: (2019)